EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
7:00am - 5:00pm 600 mins
Info
Registration Open – Hilton Union Square

Plaza A, Lobby Level

Please note: The registration desk will be open all day.

7:00am - 8:00am 60 mins
Info
Continental Breakfast – Hilton Union Square

Grand Ballroom

8:00am - 9:00am 60 mins
Info
Analyst’s pulse: What’s hot and what’s not – Hilton Union Square
  • Moderator Mark Simon - Managing Director, Torreya
  • Panelist Steve Brozak - President, WBB Securities LLC
  • Panelist Mara Goldstein - Senior Managing Director, Director of Research and Senior Analyst, Cantor Fitzgerald
  • Panelist George B. Zavoico - Senior Research Analyst, Senior VP, Equity Research, Healthcare, B. Riley FBR, Inc.

Imperial Ballroom

After a relatively good year for the biotech sector, what is in store for 2018? This panel of seasoned industry analysts will share their insights on the trends they are seeing in new therapeutic developments, the areas to watch, the disruptors and the game changers.

8:00am - 5:00pm 540 mins
Info
One-to-one meetings – Hilton Union Square

Grand Ballroom

Please note: One-to-one meetings will take place all day depending on your partnering schedule. 

8:30am - 12:00pm 210 mins
Info
Company Presentations – Hilton Union Square

Yosemite A–C; Franciscan A–D

12:00pm - 1:45pm 105 mins
Info
Lunch Plenary: Reflecting on 2017 record-breaking venture numbers: What’s behind the surge and will it continue in 2018? – Hilton Union Square
  • Moderator Ellen B. Corenswet - Partner, Covington & Burling LLP
  • Panelist Han Lee - Senior Director, Corporate Development and Ventures, AstraZeneca
  • Panelist Marian Nakada - VP, Venture Investments, Johnson & Johnson Innovation
  • Panelist Jonathan Norris - Managing Director, Sales Origination, Silicon Valley Bank
  • Panelist Art Pappas - Managing Partner, Pappas Ventures
  • Panelist Alex Zisson - Managing Director, H.I.G. Capital

Imperial Ballroom

As of November 2017, the biotech sector attracted $9.3 billion in venture funding in 471 deals, including several mega-deals such as Unity Biotechnology and ADC Therapeutics. New funds entered the space, corporate investors increased their activity, traditional biotech venture investors added new portfolio companies to their rosters and crossover investors saw a lot that they liked as well. By far, 2017 was the best year for venture funding since 2010. This panel will discuss what was behind the 2017 surge and whether it will continue in 2018.

1:45pm - 5:00pm 195 mins
Info
Company Presentations – Hilton Union Square

Yosemite A–C; Franciscan A–D

4:30pm - 5:15pm 45 mins
Info
Media roundup: Heard around the square – Hilton Union Square
  • Co-Moderator Ben Bonifant - Partner, Triangle Insights Group, LLC
  • Co-Moderator Barbara Ryan - Founder, Barbara Ryan Advisors
  • Panelist Caroline Chen - Health Reporter, Bloomberg News
  • Panelist Adam Feuerstein - Senior Writer, National Biotech Columnist, STAT
  • Panelist Ron Leuty - Biotech Reporter, San Francisco Business Times
  • Panelist Brittany Meiling - Senior Writer, Endpoints News
  • Panelist Juliet Preston - Contributing Writer, MedCity News
  • Panelist Luke Timmerman - Founder and Editor, Timmerman Report

Imperial Ballroom

As the most important week of the biotech calendar is draws to a close, join us to hear what trends and issues will reverberate in 2018. This panel of all-star reporters will provide their take on what was heard around Union Square. Who were the newsmakers? What is their analysis of the week's biggest stories? What does the industry need to prepare for next year and beyond?

5:15pm - 6:15pm 60 mins
Info
Closing reception

Grand Ballroom

Showing of Streams
5:15pm - 6:15pm

Closing reception

Grand Ballroom

More